Compare Devon Energy Corp (DVN) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Devon Energy Corp vs Twist Bioscience Corp — how do they compare? Devon Energy Corp trades at $48.84 (market cap $53.81B), while Twist Bioscience Corp trades at $154.5 (market cap $10.08B). The key difference: Devon Energy Corp is far larger — about 5.3× Twist Bioscience Corp's market cap, and Devon Energy Corp pays a 2.62% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Devon Energy Corp for 136 Days and Twist Bioscience Corp for 27 Days on average.
| DVN | TWST | |
|---|---|---|
Market Cap | $53.81B | $10.08B |
Volume | 11,556,740 | 4,229,037 |
Sector | Energy | Health |
52-Week High | $52.07 | $205.00 |
52-Week Low | $31.74 | $25.45 |
Typical Hold Time | 136 Days | 27 Days |
Enterprise Value | $64.55B | $10.01B |
Dividend Yield | 2.62% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Devon Energy (DVN) trades at $47.88, down 0.29% with a bullish technical signal from moving averages. The company shows solid fundamentals with a P/E of 10.41 and net margin of 16.67%, though revenue declined from $19.2B in 2022 to $17.2B in 2025. Recent news highlights activist investor pressure for strategic alternatives and potential asset sales, while analyst consensus remains strongly bullish with a $62.40 price target representing 30% upside.
DVN presents a compelling value opportunity with attractive valuation metrics and strong cash flow generation. However, investors face risks from oil price volatility, execution challenges in asset sales, and competitive pressures in the shale sector. The company's Permian Basin focus and potential strategic moves provide catalysts, but macroeconomic headwinds could impact near-term performance.
TWST trades at $155.65, down 6.78% today, reflecting a bearish technical signal and recent earnings misses. Revenue growth is strong, rising to $376.57M in 2025, but profitability remains elusive with a net income margin of -31.66%. The company's partnership with Lilly TuneLab for AI-driven drug discovery has generated positive news flow, yet cash flow remains negative, and the stock trades at elevated valuation multiples like P/S of 22.01.
The outlook is mixed: strong analyst buy-side consensus (73% Buy) and strategic AI partnerships offer growth potential, but persistent losses, high cash burn, and bearish technicals pose significant risks. Investors face a trade-off between long-term innovation prospects and near-term financial instability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Devon Energy Corp
Devon Energy, based in Oklahoma City, is one of the largest independent exploration and production companies in North America. The firm's asset base is spread throughout onshore North America and includes exposure to the Delaware, STACK, Eagle Ford, Powder River Basin, and Bakken plays. At year-end 2021, Devon's proved reserves totaled 1.6 billion barrels of oil equivalent, and net production that year was 572 thousand boe/d, of which oil and natural gas liquids made up 74% of production, with natural gas accounting for the remainder.
Read more on DVN →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
